A1chieve study reports

Video tutorial

Select a country or region to view the study results

Select treatment

Compare pre-study treatments

Choose measurement units

Global

You are currently viewing the overall study results for Global.
Country or region: Global
Treatment: All
Pre-treatment 1: Insulin naïve
Pre-treatment 2: Insulin users

Baseline demographics

Click here to add this chart to your selection. Click here to remove this chart from your selection. Demographics (All)

Parameters All Insulin naïve Insulin users
Number of participants 66726 44872 21854
Male (%) 37033 (55.6 %) 25702 (57.3 %) 11331 (51.9 %)
Female (%) 29623 (44.4 %) 19126 (42.7 %) 10497 (48.1 %)
Age (years) 54.0 53.2 55.6
Weight (kg) 72.9 71.7 75.3
BMI (kg/m2) 27.1 26.7 27.9
Duration of DM (years) 8.0 6.6 10.8
>2 OGLD 10981 8971 2010
No therapy 6010
HbA1c (%) 9.5 9.5 9.4
FPG (mmol/l) 10.9 11.2 10.5
PPPG (mmol/l) 15.1 15.5 14.2
Macrovascular complications, N (%) 17806 (27.2 %) 10321 (23.6 %) 7485 (34.3 %)
Microvascular complications, N (%) 35078 (53.5 %) 20753 (47.5 %) 14325 (65.7 %)

Click here to add this chart to your selection. Click here to remove this chart from your selection. Participant distribution to All by pre-study therapy

Click here to add this chart to your selection. Click here to remove this chart from your selection. Use of the different insulin types during the study (All)

Glossary

BIAsp

Biphasic insulin aspart

BMI

Body mass index

FPG

Fasting plasma glucose

HbA1c

Glycosylated haemoglobin A1c

IAsp

Insulin aspart

OGLD

Oral glucose lowering drugs

PPPG

Post prandial plasma glucose